Akebia Therapeutics Inc. (AX9)

Profile

https://www.akebia.com

Akebia Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for people living with kidney disease. Its current product portfolio centers on treatments for chronic kidney disease-related complications, including anemia management and phosphorus control, supported by a nephrology-focused commercial organization. The company’s marketed medicines are used in renal care settings and address medical needs across dialysis and non-dialysis patient populations. Akebia also maintains a development pipeline built around hypoxia-inducible factor biology, which underpins its research in kidney disease and related metabolic disorders. Headquartered in Cambridge, Massachusetts, Akebia Therapeutics Inc. serves as a specialized player in the renal therapeutics market, combining commercial products, development-stage assets, and collaboration-based programs to support treatment options in nephrology.